bone marrow transplantation in thalassemia (part 2)

نویسندگان

maryam zakerinia

چکیده

during the last two decades conventional therapy has improved the prognosis of thalassemia. however, despite such improvement it still remains a progressive disease with treatment-related complications such as hepatitis, liver fibrosis, and cardiac disease. bone marrow transplantation (bmt) can prevent or delay progression of the aforementioned complications. the importance of clinical research in the field of bmt was recognized with the award of the 1990 nobel prize in physiology and medicine to e. donnall thomas, one of the pioneers of bmt in humans. george mathe' was a pioneer in the early development of clinical bmt. mathe' and co-workers were the first to describe graft-versus-host-disease and its treatment, and the graft-versus-leukemia effect in human. the first bmt for β-thalassemia major was performed successfully by thomas and colleagues in seattle, in 1981. in the same year another patient with β-thalassemia major underwent bmt in pesaro, italy, by lucarelli and others since then, several hundred transplantations have been performed worldwide, mostly in italy. from 1991 through 2007 bmt have been performed on 497 (tehran=342, shiraz=155) blood transfusion dependent patients with thalassemia major in iran, with disease-free survival of 71-77% respectively. because of high graft failure and high rates of graft-versus-host-disease rates, bmt from alternative donors should be restricted to patients who have poor life expectancies because they cannot receive adequate conventional treatment or because of alloimmunization to minor blood antigens. beginning in the early 1980s, it was shown that umbilical cord blood contained high levels of hematopoietic progenitor cells.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Bone Marrow Transplantation in Thalassemia (Part 2)

During the last two decades conventional therapy has improved the prognosis of thalassemia. However, despite such improvement it still remains a progressive disease with treatment-related complications such as hepatitis, liver fibrosis, and cardiac disease. Bone marrow transplantation (BMT) can prevent or delay progression of the aforementioned complications. The importance of clinical research...

متن کامل

Bone Marrow Transplantation in Thalassemia (Part 1)

During the last two decades conventional therapy has improved the prognosis of thalassemia. However, despite such improvement it still remains a progressive disease with treatment-related complications such as hepatitis, liver fibrosis, and cardiac disease. Bone marrow transplantation (BMT) can prevent or delay progression of the aforementioned complications. The importance of clinical research...

متن کامل

Bone Marrow Transplantation in Thalassemia ( Part 1 )

During the last two decades conventional therapy has improved the prognosis of thalassemia. However, despite such improvement it still remains a progressive disease with treatment-related complications such as hepatitis, liver fibrosis, and cardiac disease. Bone marrow transplantation (BMT) can prevent or delay progression of the aforementioned complications. The importance of clinical research...

متن کامل

bone marrow transplantation in thalassemia (part 1)

during the last two decades conventional therapy has improved the prognosis of thalassemia. however, despite such improvement it still remains a progressive disease with treatment-related complications such as hepatitis, liver fibrosis, and cardiac disease. bone marrow transplantation (bmt) can prevent or delay progression of the aforementioned complications. the importance of clinical research...

متن کامل

Bone marrow transplantation in thalassemia.

Since 1983, 350 patients aged 1 to 19 years with beta-homozygous thalassemia were given infusions of HLA-identical marrow after high doses of busulphan and cyclophosphamide. Survival and event-free survival leveled off about 1 year after bone marrow transplantation at 82% and 75%, respectively. In 172 consecutive patients who were treated with our current regimen since June 1985, a multivariate...

متن کامل

bone marrow transplantation in patients with thalassemia

during april, 1991 and september, 1993, eighteen patients with major thalassemia admitted to shariati bmt center. seventeen patients were transplanted were from hla identical siblings and one from. his hla identical father. eleven of the donors were the known cases of minor thalassemia. the range of patients' age was within 3-10 years (with the average of 5 years and 11 months). among them...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
iranian journal of medical sciences

جلد ۳۴، شماره ۲، صفحات ۸۱-۰

کلمات کلیدی

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023